版本:
中国

BRIEF-Human Longevity says agreement with Merck KGaA, Darmstadt, Germany to engage in cancer biomarker discovery in advanced melanoma

June 15 Human longevity Inc :

* Human longevity - signed agreement with merck kgaa, darmstadt, germany which operates its biopharmaceutical business as emd serono in u.s. And canada

* Human longevity - as part of deal, co's have started joint pilot project to identify treatment response biomarker signatures in patients with advanced melanoma

* Human longevity inc says financial terms of deal were not disclosed Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐